https://procisedx.com/technology daily 0.75 2022-11-10 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581284823179-2IKIPDQCWJVX5EE8G0ZS/Procise_-_Cartridge_-_Cassette-removebg-preview.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581276031460-VYOG2LQ1QXM3C79UR93P/Pro-add2.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581276001540-1AML8GXVUBCW28KIC1ZH/Pro-run2.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581276057301-9BVHYGT4NY8VBFYDB9T1/pro-collect2.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595277492195-TE9BBSA3TPRWSXBOD2Y6/Background.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595277516345-NDFOB80KRSKMB3OF8ELU/trfretcaption.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595276468995-EP3WI0Q2V5FDACXZFIFR/Chart+for+site.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598294921771-M4LILBNWWSAWSKOYYWBE/Excitation+over+again.png Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581276261296-HIOAUMZWKXOH64YF949B/Web+Banner8.jpg Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581282292130-FUOXRUNZ19NCBGGX065A/Web+Banner9.jpg Technology https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581284724376-YO3AOBAWSOG3DGCCWAN7/Feb+Procise+Test+Home+three.png Technology https://procisedx.com/news daily 0.75 2023-06-13 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581279220504-9PJQQRVK4HJXYCK2LMRT/Web+Banner5.jpg News https://procisedx.com/news/procisedx-announces-acquisition-by-biosynex-sa-to-transform-biologics-therapeutic-drug-monitoring-in-the-us monthly 0.5 2023-06-13 https://procisedx.com/news/procisedx-announces-fda-clearance-of-procisedx-instrument-and-c-reactive-protein-crp-assay monthly 0.5 2022-11-10 https://procisedx.com/news/procisedx-announces-13-million-convertible-note-financing-and-strong-international-growth monthly 0.5 2021-07-16 https://procisedx.com/news/procisedx-secures-105-million-series-a-financing-round-led-by-biosynex-forms-an-independent-point-of-care-diagnostic-company monthly 0.5 2020-07-21 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595344673706-8T6Z8A877WS1C85L3WUX/analyzer.jpg News - ProciseDx™ Secures $10.5 Million Series A Financing Round Led by Biosynex, Forms an Independent Point-Of-Care Diagnostic Company The ProciseDx instrument is about the size of a shoe box and can provide diagnostics results in as little as 2 minutes from a finger prick drop of blood. https://procisedx.com/news/procisedx-files-510k-and-prepares-for-eu-launch-of-novel-point-of-care-technology monthly 0.5 2020-05-15 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1589562165382-LX52C7G3R6SLHDVY3TVM/Prometheus_QRG-1_Cartridge_064s-cropped_white-removebg-preview.png News - ProciseDx™ Files 510k and Prepares for EU launch of Novel Point of Care Technology ProciseDx Instrument (about 8 inches or 20cm wide) with a Procise Reagent Cartridge. https://procisedx.com/news/procisedx-announces-ce-mark-for-point-of-care-inflammatory-marker-assay monthly 0.5 2020-02-09 https://procisedx.com/news/procisedx-announces-ce-mark-for-point-of-care-platform-and-plans-for-additional-financing-in-q1-2020 monthly 0.5 2020-05-15 https://procisedx.com/contact daily 0.75 2022-04-08 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581284370645-65N11JTWMAGHH2IM5CM6/Web+Banner+fix5b.jpg Contact https://procisedx.com/about-us daily 0.75 2020-07-17 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581285103207-4FAWQSSOBDE4AY1QN8VI/Prometheus_HeroLeft_FRC_white-removebg-preview.png About Us Original https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278256738-JFXGSRDWPFO9DNLWD9WY/2.png About Us Original - Peter Westlake PRESIDENT, CFO 25 years finance and transaction experience Operational leadership, growth and international roles https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278596799-3BCMJ9NPO8VOL0B7FR9O/5.png About Us Original - David Moore, MBA Associate DIRECTOR, Marketing and BD 15 years experience developing, marketing and launching medical and diagnostic platforms. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278344987-88R8ZVRUK1O1SZ5F6VLY/3.png About Us Original - Larry Mimms CEO, CSO 35 years Diagnostic & Point of Care experience Innovation track record including successful platform launches https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278464826-3JLT7QLPPZFUWYH4W97Z/1.png About Us Original - Valerie Day, MBA VP, PRODUCT DEVELOPMENT 20 years Diagnostic and Point of Care experience Execution track record including successful platform launches https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278805725-E3F1QPNVX9L1I0GBW3HT/8.png About Us Original - David Booker, PhD DIRECTOR, AUTOMATION & INSTRUMENTATION Over 25 years experience in diagnostic instrumentation Multiple point-of-care instrument product launches https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278697340-I8IS0EU06QY1TMALFIWR/6.png About Us Original - Kurt Bray, PhD DIRECTOR, CLINICAL DEV & MEDICAL AFFAIRS 35 years of in-vitro diagnostic research and product R&D. Multiple PMA approvals, 510(k) clearances, international trials and regulatory approvals. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278533918-2OVETZVAR2VEYJNZRJD4/4.png About Us Original - Michael Hale, PhD VP, RESEARCH & DEVELOPMENT 13 years diagnostic and Point-of-Care experience Proven track record in all aspects of development and FDA clearance https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278753145-ZTXTJGT32LYQOC2RGKD2/7.png About Us Original - Dan Kiser, MBA VP, QUALITY & REGULATORY 25 years in Medical Device Quality Regulatory Specializes in FDA and ISO Compliance https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581284968989-OI1G4LIGZ8A19IZ6TSAP/Feb+Procise+Test+Home+three+%281%29.png About Us Original https://procisedx.com/home daily 1.0 2020-08-28 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581272860751-1Z9XRY6GC5IQVB2WF3NP/Prometheus_QRG-1_Cartridge_064s-cropped_white-removebg-preview.png Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1583163664234-ZRU3E9L7Y6PY4O6EK5G6/bar_dot-04_40.png Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1583162794022-3D79MUABJF491QDSGRLW/Procise-Image-Title2+%282%29.png Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1583163396437-DCMUZ6REOJKFK6YAMUN0/Pro-Expl-5_67.png Home - Immediate. Total turnaround time is only 2 to 5 minutes. Every minute matters during a patient appointment or pharmacy visit. 10, 15, 20 minutes? That’s not point-of-care. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1583163060556-LA6EO1I7OYP7F6MMEHRN/Pro-Expl-3_1_67.png Home - Easy. A finger-prick sample and minimal staff training is all you need. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1583163584032-6KTZ05TKGTD7TOJOB1I4/bar_dot-03_40.png Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1583163095746-1XAB86IRGXGCFUU1PWA0/bar_dot-01_40.png Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1583163706519-Q23YKS8XTS7OILLD4Y9Z/Pro-Expl-7_67.png Home - Accurate. Central-lab quality, sensitivity and specificity. Healthcare professionals are not willing to give up lab-quality results to point-of-care. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1578797704146-O0AJZ14EHLONQZRKZTI1/Web+Banner9.jpg Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1578799557894-ES87FR95K57IXKGPH65V/Web+Banner5.jpg Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1578851913750-YDAEXTI9K2J7W8F8IA6W/Web+Banner7.jpg Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581282238663-0K4CIUV70GXHSPJZ2GKK/Feb+Procise+Test+Home+two.png Home https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581283691661-0P38ID6CSHDFBWZGH43K/Prometheus_HeroFront_FRC_white+%281%29.jpg Home https://procisedx.com/menu daily 0.75 2021-01-28 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596483991013-5I28GTXMXZHLTCTGLSO5/2.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596483933270-IGXY89XORBO6KHM33KOY/3.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596487347405-GZAAN7OHTKNBDGT8PCP9/Copy+of+Menu+Buttons.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596483974648-U4UYBCXHWFU4E8OMRGVB/1.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1593016448761-ONKBKZF76TEUDEDTQIGK/CRP+molecule.PNG Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596487383324-4GKPJC2MTM6JM0YNK8IS/%5BPRO%5D+501+-+ProciseDx+Additional+Brandmarks+R2.00_CRP.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488720514-R0WPQ6WH712M50LJYCUQ/Red+line+accent.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596487407201-ANQC7DMG55LL5X358Y95/%5BPRO%5D+501+-+ProciseDx+Additional+Brandmarks+R2.00_FCP.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488909355-HRCY8O1C6J82E4ROXQH6/FCP+molecule+larger.PNG Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488782641-KEUS64OSNB6OY0CIE9VP/Red+line+accent.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488690287-1325RQ6OAJMJRM6ES2GB/Purple+line+accent.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595272003446-8YY74J4HX0CSPDDOF3MO/IFX+logo.PNG Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595272094170-OLNF56J1YM5RE60M8QLV/IFX+molecule.PNG Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598895107696-3XABPSA25YQFZJ127UZC/New+ADL+molecule.PNG Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488594229-OQNKPG2KTBOTT6Z2BHKI/Purple+line+accent.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595272190453-KRX2K37UDMM50RSCOX05/ADL+logo.PNG Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1594234827679-TUZEY1Z90410RWWG7EC8/Menu+banner+1.png Assay Menu https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596489085118-ZJKHG4C6Y411IT4AS5JR/Brand+Lines+background+%281%29.png Assay Menu https://procisedx.com/executive-team-procisedx daily 0.75 2023-08-21 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278533918-2OVETZVAR2VEYJNZRJD4/4.png About Us - Michael Hale, PhD VP, RESEARCH & DEVELOPMENT 13 years diagnostic and Point-of-Care experience Proven track record in all aspects of development and FDA clearance https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1581278464826-3JLT7QLPPZFUWYH4W97Z/1.png About Us - Valerie Day, MS, MBA sVP, PRODUCT DEVELOPMENT 20 years Diagnostic and Point of Care experience Execution track record including successful platform launches https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598630904622-FFMH8SUEW8OFWQ4OK136/3.png About Us - Larry Mimms president, CSO, BOARD OF DIRECTORS 35 years Diagnostic & Point of Care experience Innovation track record including successful platform launches https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598631419318-391015C1YHID9VGGHZ6R/6.png About Us - Kurt Bray, PhD Mark Qillaq Aliquam bibendum, turpis eu mattis iaculis, ex lorem mollis sem, ut sollicitudin risus orci quis tellus. Nullam sit amet nisi condimentum erat iaculis auctor. Donec eget risus diam. Aliquam bibendum, turpis eu mattis iaculis, ex lorem mollis sem, ut sollicitudin risus orci quis tellus. Donec eu est non lacus lacinia semper. Integer tempus, elit in laoreet posuere, lectus neque blandit dui, et placerat urna diam mattis orci. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598631329632-Z3XTFR7KJKXVSIVQQRSC/8.png About Us - David Booker, PhD Emily Sung Lorem ipsum dolor sit amet, consectetur adipiscing elit. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Vivamus sit amet semper lacus, in mollis libero. Suspendisse nec congue purus. Nulla lectus ante, consequat et ex eget, feugiat tincidunt metus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae. Nullam sit amet nisi condimentum erat iaculis auctor. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598633889521-235OFMUKX6QRH6NCDI8K/Prometheus_HeroLeft_FRC_white-removebg-preview.png About Us https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598633789419-UXVXCZ6YOZJYAB3R4QN4/Untitled+design+%2835%29.png About Us https://procisedx.com/team-gallery-test daily 0.75 2020-08-24 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598296263800-GRQC7G0FGWA06F931PVF/image-asset.png Team Gallery Test - Jacques Cavadenti Dr. Mimms is currently CEO of ProciseDx in San Diego. He was Chief Scientific Officer at Prometheus Laboratories (2015 to 2019). From 2009 to 2015, Dr. Mimms served as Vice President R&D Quidel Corp., a world leader in development of point of care, rapid tests. He also teaches a course at UCSD Extension on in vitro diagnostic product development around which a certification program has been developed. Prior to his work at Quidel, Dr. Mimms founded VDx LLC in 2008 to develop rapid, point of care HIV diagnostic tests. From 1994 to 2007 Dr. Mimms held a number of Executive positions at Gen-Probe Incorporated including Executive Vice President, Research and Development from 2005-2007 and Vice President, Development, Blood and Vice President of Strategic Planning and Business Development. Dr. Mimms initiated and headed up the Gen-Probe blood bank program from 1996 to 2002. In 1996, he and his colleagues won a National Institutes of Health (NIH) contract to develop blood screening assays to detect HIV and HCV nucleic acid. This work and later contracts led to FDA licensure and market introduction of Procleix HIV-1/HCV, Ultrio HIV-1/HCV/HBV assay and the Procleix West Nile Virus assay. As a result of this work, Gen-Probe won the 2004 National Medal of Technology, the highest U.S. honor for technological innovation, for “development and commercialization of new blood testing technologies and systems for the direct detection of viral diseases.” Dr Mimms served as a member of the Blue Ribbon R&D Panel for the American Red Cross from 2006-2007. Prior to Joining Gen-Probe, Dr, Mimms held various positions in the Hepatitis/AIDS Business Unit at Abbott Laboratories. He was an NIH Postdoctoral Fellow at Harvard University in Cellular and Developmental Biology prior to joining Abbott Laboratories. He earned a Ph.D. in biochemistry from Duke University and a B.S. in chemistry from Davidson College. In 2014 Dr. Mimms received an honorary doctorate in science from Davidson College for his work on HIV, HCV and HBV. Dr. Mimms was awarded the 2017AACC Edwin F. Ullman Award for Technology Innovation. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598296263800-GRQC7G0FGWA06F931PVF/image-asset.png Team Gallery Test - Jacques Cavadenti Dr. Mimms is currently CEO of ProciseDx in San Diego. He was Chief Scientific Officer at Prometheus Laboratories (2015 to 2019). From 2009 to 2015, Dr. Mimms served as Vice President R&D Quidel Corp., a world leader in development of point of care, rapid tests. He also teaches a course at UCSD Extension on in vitro diagnostic product development around which a certification program has been developed. Prior to his work at Quidel, Dr. Mimms founded VDx LLC in 2008 to develop rapid, point of care HIV diagnostic tests. From 1994 to 2007 Dr. Mimms held a number of Executive positions at Gen-Probe Incorporated including Executive Vice President, Research and Development from 2005-2007 and Vice President, Development, Blood and Vice President of Strategic Planning and Business Development. Dr. Mimms initiated and headed up the Gen-Probe blood bank program from 1996 to 2002. In 1996, he and his colleagues won a National Institutes of Health (NIH) contract to develop blood screening assays to detect HIV and HCV nucleic acid. This work and later contracts led to FDA licensure and market introduction of Procleix HIV-1/HCV, Ultrio HIV-1/HCV/HBV assay and the Procleix West Nile Virus assay. As a result of this work, Gen-Probe won the 2004 National Medal of Technology, the highest U.S. honor for technological innovation, for “development and commercialization of new blood testing technologies and systems for the direct detection of viral diseases.” Dr Mimms served as a member of the Blue Ribbon R&D Panel for the American Red Cross from 2006-2007. Prior to Joining Gen-Probe, Dr, Mimms held various positions in the Hepatitis/AIDS Business Unit at Abbott Laboratories. He was an NIH Postdoctoral Fellow at Harvard University in Cellular and Developmental Biology prior to joining Abbott Laboratories. He earned a Ph.D. in biochemistry from Duke University and a B.S. in chemistry from Davidson College. In 2014 Dr. Mimms received an honorary doctorate in science from Davidson College for his work on HIV, HCV and HBV. Dr. Mimms was awarded the 2017AACC Edwin F. Ullman Award for Technology Innovation. https://procisedx.com/partner-portal daily 0.75 2020-09-14 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595618537043-4LTR42KE9E9TTQJ03O1Z/Menu+banner+1.png Partner Portal https://procisedx.com/crp-index daily 0.75 2020-10-13 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503645700-V3XJ89OGCBOA6UFS80NR/%5BPRO%5D+501+-+ProciseDx+Additional+Brandmarks+R2.00_CRP.jpg CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503748893-RHQ0KQM22O5HNH1EV0HC/CRP+molecule.PNG CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503667533-2L4YVY4FF186E7B39EA3/Red+line+accent.png CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598480746597-OXG45I2LJ2HTB60F69H0/Small+brand+lines.png CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598480697194-94X9ZUUP77RAQ6UG27FG/Small+brand+lines+2.png CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598480635499-7I6KM79RBMO5UFFSUQ3Y/%5BPRO%5D+501+-+ProciseDx+Additional+Brandmarks+R2.00_CRP.jpg CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503969712-OJZBSLTZ4FXI9GGCHWPQ/CRP+performance+right.PNG CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503951976-GEAR44J3HXI8C61ENNLN/CRP+Performance+left.PNG CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503590491-UUJNM80B7C2QAADHZ5U6/Web+Banner6.jpg CRP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596504212113-6WSHZVAI31X2ZG2A9TI6/Web+Banner6.jpg CRP Index https://procisedx.com/adl-index daily 0.75 2023-10-04 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596502377102-0N9AIGNYJ0A5J7KOE70C/ADL+wordmark.PNG ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488690287-1325RQ6OAJMJRM6ES2GB/Purple+line+accent.png ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598895006545-QJO0YLXXLK64Z8LJOX8W/New+ADL+molecule.PNG ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596502512711-9YSI5CWK34LB2AC9GUEQ/ADL+wordmark.PNG ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596492875172-DSMRMMDYK7V0LW0HIP3Y/Small+brand+lines.png ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596499962982-MG7G1HWYRCU1RT5ZEFJR/Small+brand+lines+2.png ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598293379227-9LBMM8FUT2LX0NMDYRAJ/ADL+first+chart.PNG ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598293398331-GLQ0G0I68OZ3K557KAFO/ADL+second+chart.PNG ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596502333913-5AIY6LAV0N37GLVH408N/Web+Banner9.jpg ADL Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503377621-DL0ZV4541FGK643O9F7U/Web+Banner9.jpg ADL Index https://procisedx.com/ifx-index daily 0.75 2023-09-15 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488690287-1325RQ6OAJMJRM6ES2GB/Purple+line+accent.png IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595272094170-OLNF56J1YM5RE60M8QLV/IFX+molecule.PNG IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1595272003446-8YY74J4HX0CSPDDOF3MO/IFX+logo.PNG IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596491363091-X0TH8YMIP1UP4GWNJN1B/%5BPRO%5D+501+-+ProciseDx+Additional+Brandmarks+R2.00_IFX.png IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596499962982-MG7G1HWYRCU1RT5ZEFJR/Small+brand+lines+2.png IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596492875172-DSMRMMDYK7V0LW0HIP3Y/Small+brand+lines.png IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598292741138-60XV78I3J37TE4SZPDPT/IFX+second+chart.PNG IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598292787270-3PCHY5FQXAFQDVTOKW3Z/IFX+first+chart.PNG IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596502217218-IN3HCYIRPFB36DGX4X10/Web+Banner9.jpg IFX Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503377621-DL0ZV4541FGK643O9F7U/Web+Banner9.jpg IFX Index https://procisedx.com/fcp-index daily 0.75 2021-12-15 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596487407201-ANQC7DMG55LL5X358Y95/%5BPRO%5D+501+-+ProciseDx+Additional+Brandmarks+R2.00_FCP.png FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503667533-2L4YVY4FF186E7B39EA3/Red+line+accent.png FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596488909355-HRCY8O1C6J82E4ROXQH6/FCP+molecule+larger.PNG FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598480697194-94X9ZUUP77RAQ6UG27FG/Small+brand+lines+2.png FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598480746597-OXG45I2LJ2HTB60F69H0/Small+brand+lines.png FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1611858257689-TNOHPS71BHPUTIWEZSPN/FCP+Comparison+Graph.PNG FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1611954905661-QTQSVFFKGS53Q83S2RME/SCD+Benefits.PNG FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503590491-UUJNM80B7C2QAADHZ5U6/Web+Banner6.jpg FCP Index https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596504212113-6WSHZVAI31X2ZG2A9TI6/Web+Banner6.jpg FCP Index https://procisedx.com/june2021webinar daily 0.75 2021-07-01 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1618867051861-PAW1M2FGLIJBE8OE8QFR/Foto+ES.jpg June2021Webinar - Pr. Edoardo Savarino University of Padova, Italy https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1618866741466-V7LYJLPSS5HA0AR9LS56/Geert-DHaens_280x350.jpg June2021Webinar - Pr. Geert D’Haens Amsterdam Medical Center https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1596503590491-UUJNM80B7C2QAADHZ5U6/Web+Banner6.jpg June2021Webinar https://procisedx.com/new-gallery-1 daily 0.75 2025-06-10 https://images.squarespace-cdn.com/content/v1/56098193e4b08650938b4d7b/1532270564524-GUN9AMWKT65P928CA3T4/51_HBL_Pickles_v1-276.jpg New Gallery https://images.squarespace-cdn.com/content/v1/56098193e4b08650938b4d7b/1532270564524-GUN9AMWKT65P928CA3T4/51_HBL_Pickles_v1-276.jpg New Gallery https://procisedx.com/intl-redirection daily 0.75 2020-07-08 https://procisedx.com/terms-and-conditions daily 0.75 2020-02-09 https://procisedx.com/biosynex-procise-covid daily 0.75 2020-08-24 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1594155276154-LL6WNWBKZOYY5DTR6J6B/obi-onyeador-PMnbMcJeftk-unsplash.jpg COVID Ab Testing - The BIOSYNEX COVID-19 BSS is a rapid test for the qualitative detection of antibodies (IgG and IgM) against SARS-CoV-2. ProciseDx is the exclusive import partner of Biosynex for their COVID-19 BSS test in the United States. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1594156170829-SIN48IDY5Y0IUBNGI3K7/COVID+left+loop.png COVID Ab Testing https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1593014894005-2X9YK72HTIT1J7E47Y7Q/COVID+Test+3D+-+Vertical.png COVID Ab Testing https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1591974447382-RDDJS0A1JIAZ49ILGCVO/COVID+workflow2.png COVID Ab Testing https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598295083978-2MBXYBDC8P20WANTLXJ8/Ideal+Testing+Window_Chart-01.jpg COVID Ab Testing https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1594159742665-V9IMHXYATUH63CGS7C36/serological+square+3+%281%29.png COVID Ab Testing - WHY USE A SEROLOGICAL TEST FOR COVID-19? Tests based on antibody testing are used to check whether antibodies to SARS-CoV-2 have developed. They can identify people who were not known to be infected, either because they never developed symptoms or because they had mild symptoms. Studies show that positive antibody levels are very low in the first five days after the onset of symptoms (less than 50%) and then rise rapidly as the disease progresses. After 11 days, positive antibody levels rise to over 80%. Serological testing can be very useful in the surveillance and monitoring of COVID-19. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1591910592280-CZ5A5R5XH2WLV82FA0B4/COVID+Banner+test+4.png COVID Ab Testing https://procisedx.com/larrybio daily 0.75 2020-08-28 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598634746140-8FSCS1OJEP5XWMCNIKZH/3.png Larry's Bio https://procisedx.com/larry-abensure daily 0.75 2020-08-28 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598635389982-16F3GHALCP7A3RABODSH/Untitled+design+%2834%29.png Larry Abensur https://procisedx.com/peters-bio daily 0.75 2022-11-10 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598634295567-EPVPT1S86O5YA3NBRWM7/Untitled+design+%2828%29.png Peter's Bio https://procisedx.com/covid-ab-testing-backup-copy daily 0.75 2020-08-13 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1593014894005-2X9YK72HTIT1J7E47Y7Q/COVID+Test+3D+-+Vertical.png COVID Ab Testing (Backup Copy) https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1594156170829-SIN48IDY5Y0IUBNGI3K7/COVID+left+loop.png COVID Ab Testing (Backup Copy) https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1594159742665-V9IMHXYATUH63CGS7C36/serological+square+3+%281%29.png COVID Ab Testing (Backup Copy) - WHY USE A SEROLOGICAL TEST FOR COVID-19? Tests based on antibody testing are used to check whether antibodies to SARS-CoV-2 have developed. They can identify people who were not known to be infected, either because they never developed symptoms or because they had mild symptoms. Studies show that positive antibody levels are very low in the first five days after the onset of symptoms (less than 50%) and then rise rapidly as the disease progresses. After 11 days, positive antibody levels rise to over 80%. Serological testing can be very useful in the surveillance and monitoring of COVID-19. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1594155276154-LL6WNWBKZOYY5DTR6J6B/obi-onyeador-PMnbMcJeftk-unsplash.jpg COVID Ab Testing (Backup Copy) - The BIOSYNEX COVID-19 BSS is a rapid test for the qualitative detection of antibodies (IgG and IgM) against SARS-CoV-2. ProciseDx is the exclusive import partner of Biosynex for their COVID-19 BSS test in the United States. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1591974447382-RDDJS0A1JIAZ49ILGCVO/COVID+workflow2.png COVID Ab Testing (Backup Copy) https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1591910592280-CZ5A5R5XH2WLV82FA0B4/COVID+Banner+test+4.png COVID Ab Testing (Backup Copy) https://procisedx.com/bod daily 0.75 2020-08-28 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598632217424-VCRDMMM4D5REBJ4FJJJO/Untitled+design+%2830%29.png Board of Directors - Magda Marquet, Ph.D. Co-Founder AltheaDx and ALMA Life Sciences Mark Lee Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae. Fusce at massa nec sapien auctor gravida in in tellus. Mauris egestas at nibh nec finibus. Donec eget risus diam. Mauris egestas at nibh nec finibus. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598632417608-5E3Q7SJ6QTBX8QRI1IZ3/Untitled+design+%2834%29.png Board of Directors - Larry Abensur Founder of Biosynex SA, Dectra Pharm SAS and All Diag Roy Hill Fusce at massa nec sapien auctor gravida in in tellus. Maecenas non leo laoreet, condimentum lorem nec, vulputate massa. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus a ante congue, porta nunc nec, hendrerit turpis. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598632538874-SZZ2PR5I6B2QDUJ33KXP/Untitled+design+%2832%29.png Board of Directors - Martin Hendrix Head of Global Business Development and M&A, Nestlé Health Science Jeremy Edwards Nulla eu pretium massa. Mauris egestas at nibh nec finibus. Quisque congue porttitor ullamcorper. Vivamus a ante congue, porta nunc nec, hendrerit turpis. https://procisedx.com/martin-hendrix daily 0.75 2020-08-28 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598635787559-CAG54WNZLQJCUSCKCTKF/Untitled+design+%2832%29.png Martin Hendrix https://procisedx.com/magdas-bio daily 0.75 2020-08-28 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598634939209-O4TKQC5VM11A1X01O9MY/Untitled+design+%2830%29.png Magda's Bio https://procisedx.com/board-of-directors daily 0.75 2022-11-03 https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1600374158361-E3DE484WHEBPW8IAVZKO/Untitled+design+%2828%29.png Board of Directors - Standalone - Peter Westlake CEO & CFO, BOARD OF DIRECTORS https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1600374861338-ILRAS9Z0EMJ1AITNI1XC/3.png Board of Directors - Standalone - Larry Mimms President & CSO, BOARD OF DIRECTORS https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598632417608-5E3Q7SJ6QTBX8QRI1IZ3/Untitled+design+%2834%29.png Board of Directors - Standalone - Larry Abensur Founder of Biosynex SA, Dectra Pharm SAS and All Diag Roy Hill Fusce at massa nec sapien auctor gravida in in tellus. Maecenas non leo laoreet, condimentum lorem nec, vulputate massa. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus a ante congue, porta nunc nec, hendrerit turpis. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598632217424-VCRDMMM4D5REBJ4FJJJO/Untitled+design+%2830%29.png Board of Directors - Standalone - Magda Marquet, Ph.D. Co-Founder AltheaDx and ALMA Life Sciences Mark Lee Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae. Fusce at massa nec sapien auctor gravida in in tellus. Mauris egestas at nibh nec finibus. Donec eget risus diam. Mauris egestas at nibh nec finibus. https://images.squarespace-cdn.com/content/v1/5e1a8289c429c302ddea1459/1598632538874-SZZ2PR5I6B2QDUJ33KXP/Untitled+design+%2832%29.png Board of Directors - Standalone - Martin Hendrix Head of Global Business Development and M&A, Nestlé Health Science Jeremy Edwards Nulla eu pretium massa. Mauris egestas at nibh nec finibus. Quisque congue porttitor ullamcorper. Vivamus a ante congue, porta nunc nec, hendrerit turpis.